ISO-690 (author-date, English)

CHIOREAN, Roxana, BAICAN, Adrian, MUSTAFA, Mayson Badreldeen Abdalla, LISCHKA, Annette, LEUCUTA, Daniel Corneliu, FELDRIHAN, Vasile, HERTL, Michael und SITARU, Cassian, 2019. Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients. Freiburg: Universität.

Elsevier - Harvard (with titles)

Chiorean, R., Baican, A., Mustafa, M.B.A., Lischka, A., Leucuta, D.C., Feldrihan, V., Hertl, M., Sitaru, C., 2019. Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients. Universität, Freiburg. https://doi.org/10.3389/fimmu.2018.02687

American Psychological Association 7th edition

Chiorean, R., Baican, A., Mustafa, M. B. A., Lischka, A., Leucuta, D. C., Feldrihan, V., Hertl, M., & Sitaru, C. (ca. 2019). Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients [Cd]. Universität. https://doi.org/10.3389/fimmu.2018.02687

Springer - Basic (author-date)

Chiorean R, Baican A, Mustafa MBA, Lischka A, Leucuta DC, Feldrihan V, Hertl M, Sitaru C (2019) Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients. Universität, Freiburg

Juristische Zitierweise (Stüber) (Deutsch)

Chiorean, Roxana/ Baican, Adrian/ Mustafa, Mayson Badreldeen Abdalla/ Lischka, Annette/ Leucuta, Daniel Corneliu/ Feldrihan, Vasile/ Hertl, Michael/ Sitaru, Cassian, Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients, Freiburg 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.